Takeda Partners with Insilico Medicine to Advance AI Drug Discovery
Takeda Pharmaceutical has finalized a strategic collaboration with Insilico Medicine, valued at up to US$600 million, to leverage artificial intelligence for multi-target drug discovery. The partnership utilizes Insilico’s proprietary Pharma.AI ... Read More